₹75.97
+1.06
(+1.42%)
as on
as on September 12, 2025 at 4:02 pm IST
Day's Low
Day's High
2.45%
Downside
1.03%
Upside
52 Week's Low
52 Week's High
9.04%
Downside
68.49%
Upside
as on September 12, 2025 at 4:02 pm IST
Market Cap
₹370.17 Cr
Return on Equity (ROE)
4.93
PE Ratio (TTM)
39.16
Return on capital employed (ROCE)
8.21
Industry PE ratio
42.64
Beta (LTM)
0.87
P/B Ratio
1.61
Dividend Yield
0PEG Ratio
-22.64
Quarterly Earnings Growth YOY
-307.78
EPS (TTM)
2.5
Sector
Pharmaceuticals
Book Value
51.49
Technical Analysis
Bearish
View Technical Analysis
as on September 12, 2025 at 4:02 pm IST
Zim Laboratories Ltd in the last 5 years
Lowest (6.12x)
June 11, 2018
Today (39.16x)
September 12, 2025
Industry (42.64x)
September 12, 2025
Highest (198.80x)
July 1, 2021
Today’s Price to Earnings Ratio: 39.16x
Compare market cap, revenue, PE, and other key metrics of Zim Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 370.17 | -3.02% | 0.66 | 12 | 379 | |
NA | 257.93 | 34.13% | 0.56 | 13 | 86 | |
NA | 7,543.81 | 6.85% | 0.51 | 266 | 2,108 | |
NA | 101.33 | 35.94% | 0.00 | 7 | 285 | |
NA | 931.79 | 40.83% | 0.75 | -44 | 340 |
Search interest for Zim Laboratories Ltd Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
Numbers in percentages
View detailed summary of the earnings and dividend history of Zim Laboratories Ltd.
Zim Laboratories Ltd’s net profit fell -307.78% since last year same period to ₹-1.87Cr in the Q1 2025-2026. On a quarterly growth basis, Zim Laboratories Ltd has generated -138.32% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Zim Laboratories Ltd has declared dividend of ₹0.50 per share on 22 May 2019 - translating a dividend yield of 1.97%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.01% to 0.03% in Jun 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 33.26% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 9.6% return, outperforming this stock by 43.8%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.9% return, outperforming this stock by 206.4%
Revenue Fall
Revenue is down for the last 2 quarters, 110.44 Cr → 73.23 Cr (in ₹), with an average decrease of 33.7% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 66.49% to 66.46% in Jun 2025 quarter
Profit Down
Netprofit is down for the last 2 quarters, 4.88 Cr → -1.87 Cr (in ₹), with an average decrease of 138.3% per quarter
Price Dip
In the last 3 months, ZIMLAB stock has moved down by -26.8%
Organisation | Zim Laboratories Ltd |
Industry | Pharmaceuticals |
CEO | Anwar S Daud |
E-voting on shares | Click here to vote |
Zim Laboratories Ltd share price today stands at ₹75.97 as on at the close of the market. Zim Laboratories Ltd share today touched a day high of ₹76.75 and a low of ₹74.11.
Zim Laboratories Ltd touched a 52 week high of ₹128 and a 52 week low of ₹69.1. Zim Laboratories Ltd share price today i.e. is closed at ₹75.97, which is -40.65% down from its 52 week high and 9.94% up from its 52 week low.
Zim Laboratories Ltd market capitalisation is ₹370.17 Cr as on .
To buy Zim Laboratories Ltd shares, you need to follow these steps:
Zim Laboratories Ltd trading volume is 69.48K as on . This means that 69.48K shares of Zim Laboratories Ltd were bought and sold on the stock market during today's trading session.